• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为药物研发靶点类别的蛋白质甲基转移酶

Protein methyltransferases as a target class for drug discovery.

作者信息

Copeland Robert A, Solomon Michael E, Richon Victoria M

机构信息

Epizyme, Inc., 840 Memorial Drive, Cambridge, Massachussets 02139, USA.

出版信息

Nat Rev Drug Discov. 2009 Sep;8(9):724-32. doi: 10.1038/nrd2974.

DOI:10.1038/nrd2974
PMID:19721445
Abstract

The protein methyltransferases (PMTs) - which methylate protein lysine and arginine residues and have crucial roles in gene transcription - are emerging as an important group of enzymes that play key parts in normal physiology and human diseases. The collection of human PMTs is a large and diverse group of enzymes that have a common mechanism of catalysis. Here, we review the biological, biochemical and structural data that together present PMTs as a novel, chemically tractable target class for drug discovery.

摘要

蛋白质甲基转移酶(PMTs)——可使蛋白质赖氨酸和精氨酸残基发生甲基化,在基因转录中起关键作用——正成为一类重要的酶,在正常生理和人类疾病中发挥关键作用。人类PMTs是一组庞大且多样的酶,具有共同的催化机制。在此,我们综述生物学、生物化学和结构数据,这些数据共同表明PMTs是一类用于药物发现的新型、化学上易于处理的靶点。

相似文献

1
Protein methyltransferases as a target class for drug discovery.作为药物研发靶点类别的蛋白质甲基转移酶
Nat Rev Drug Discov. 2009 Sep;8(9):724-32. doi: 10.1038/nrd2974.
2
Protein methyltransferase inhibitors as precision cancer therapeutics: a decade of discovery.蛋白甲基转移酶抑制剂作为精准癌症治疗药物:十年的探索。
Philos Trans R Soc Lond B Biol Sci. 2018 Jun 5;373(1748). doi: 10.1098/rstb.2017.0080.
3
Recent progress in developing selective inhibitors of protein methyltransferases.蛋白质甲基转移酶选择性抑制剂开发的最新进展。
Curr Opin Chem Biol. 2017 Aug;39:100-108. doi: 10.1016/j.cbpa.2017.06.013. Epub 2017 Jun 26.
4
Targeting genetic alterations in protein methyltransferases for personalized cancer therapeutics.针对蛋白质甲基转移酶的遗传改变进行个体化癌症治疗。
Oncogene. 2013 Feb 21;32(8):939-46. doi: 10.1038/onc.2012.552. Epub 2012 Nov 19.
5
A high throughput scintillation proximity imaging assay for protein methyltransferases.一种用于蛋白质甲基转移酶的高通量闪烁邻近成像分析方法。
Comb Chem High Throughput Screen. 2012 Jun 1;15(5):359-71. doi: 10.2174/138620712800194468.
6
Selective inhibitors of protein methyltransferases.蛋白甲基转移酶选择性抑制剂。
J Med Chem. 2015 Feb 26;58(4):1596-629. doi: 10.1021/jm501234a. Epub 2014 Dec 2.
7
Inhibitors of Protein Methyltransferases and Demethylases.蛋白质甲基转移酶和去甲基酶抑制剂。
Chem Rev. 2018 Feb 14;118(3):989-1068. doi: 10.1021/acs.chemrev.6b00801. Epub 2017 Mar 24.
8
Molecular pathways: protein methyltransferases in cancer.分子通路:癌症中的蛋白甲基转移酶。
Clin Cancer Res. 2013 Dec 1;19(23):6344-50. doi: 10.1158/1078-0432.CCR-13-0223. Epub 2013 Aug 19.
9
Chemical Inhibition of Protein Methyltransferases.蛋白质甲基转移酶的化学抑制。
Cell Chem Biol. 2016 Sep 22;23(9):1067-1076. doi: 10.1016/j.chembiol.2016.07.014. Epub 2016 Aug 25.
10
Inhibitors of protein methyltransferases as chemical tools.作为化学工具的蛋白质甲基转移酶抑制剂
Epigenomics. 2015;7(8):1327-38. doi: 10.2217/epi.15.87. Epub 2015 Dec 8.

引用本文的文献

1
Investigation of a squaramide motif as a bioisostere of the amino-acid group of S-adenosyl-L-methionine and its functional impact on RNA methylation.对作为S-腺苷-L-甲硫氨酸氨基酸基团生物电子等排体的方酰胺基序进行研究及其对RNA甲基化的功能影响。
Commun Chem. 2025 Aug 12;8(1):244. doi: 10.1038/s42004-025-01627-7.
2
Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance.将表观遗传调节因子作为克服癌症治疗耐药性的一条有前景的途径。
Signal Transduct Target Ther. 2025 Jul 18;10(1):219. doi: 10.1038/s41392-025-02266-z.
3
Polycomb repressive complex 2 (PRC2) pathway's role in cancer cell plasticity and drug resistance.

本文引用的文献

1
Optimization of pyrazole inhibitors of Coactivator Associated Arginine Methyltransferase 1 (CARM1).共激活因子相关精氨酸甲基转移酶1(CARM1)的吡唑类抑制剂的优化
Bioorg Med Chem Lett. 2009 Jun 1;19(11):2924-7. doi: 10.1016/j.bmcl.2009.04.075. Epub 2009 Apr 22.
2
Therapeutic targeting of MLL.MLL的治疗靶向
Blood. 2009 Jun 11;113(24):6061-8. doi: 10.1182/blood-2008-12-197061. Epub 2009 Mar 16.
3
Panobinostat treatment depletes EZH2 and DNMT1 levels and enhances decitabine mediated de-repression of JunB and loss of survival of human acute leukemia cells.
多梳抑制复合物2(PRC2)通路在癌细胞可塑性和耐药性中的作用。
Funct Integr Genomics. 2025 Mar 6;25(1):53. doi: 10.1007/s10142-025-01563-8.
4
Emerging Trends in Neuroblastoma Diagnosis, Therapeutics, and Research.神经母细胞瘤诊断、治疗与研究的新趋势
Mol Neurobiol. 2025 May;62(5):6423-6466. doi: 10.1007/s12035-024-04680-w. Epub 2025 Jan 13.
5
SETD7 promotes LC3B methylation and degradation in ovarian cancer.SETD7促进卵巢癌中LC3B的甲基化和降解。
J Biol Chem. 2025 Feb;301(2):108134. doi: 10.1016/j.jbc.2024.108134. Epub 2024 Dec 25.
6
Therapeutic targeting potential of the protein lysine and arginine methyltransferases to reverse cancer chemoresistance.蛋白质赖氨酸和精氨酸甲基转移酶逆转癌症化疗耐药性的治疗靶向潜力。
Front Mol Biosci. 2024 Dec 5;11:1455415. doi: 10.3389/fmolb.2024.1455415. eCollection 2024.
7
DOT1L Mediates Stem Cell Maintenance and Represents a Therapeutic Vulnerability in Cancer.DOT1L介导干细胞维持并代表癌症中的一个治疗弱点。
Cancer Res. 2025 Mar 3;85(5):838-847. doi: 10.1158/0008-5472.CAN-24-3304.
8
PRMT5/WDR77 Enhances the Proliferation of Squamous Cell Carcinoma via the ΔNp63α-p21 Axis.PRMT5/WDR77 通过 ΔNp63α-p21 轴增强鳞状细胞癌的增殖。
Cancers (Basel). 2024 Nov 11;16(22):3789. doi: 10.3390/cancers16223789.
9
Structure, Function, and Activity of Small Molecule and Peptide Inhibitors of Protein Arginine Methyltransferase 1.小分子和肽类蛋白精氨酸甲基转移酶 1 抑制剂的结构、功能和活性。
J Med Chem. 2024 Sep 26;67(18):15931-15946. doi: 10.1021/acs.jmedchem.4c00490. Epub 2024 Sep 9.
10
PMTPred: machine-learning-based prediction of protein methyltransferases using the composition of k-spaced amino acid pairs.PMTPred:基于k间隔氨基酸对组成的蛋白质甲基转移酶的机器学习预测
Mol Divers. 2024 Aug;28(4):2301-2315. doi: 10.1007/s11030-024-10937-2. Epub 2024 Jul 21.
帕比司他治疗可降低EZH2和DNMT1水平,并增强地西他滨介导的对JunB的去抑制作用以及人急性白血病细胞的存活丧失。
Cancer Biol Ther. 2009 May;8(10):939-50. doi: 10.4161/cbt.8.10.8213. Epub 2009 May 18.
4
PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing.PRMT5介导的组蛋白H4R3甲基化招募DNMT3A,在基因沉默中耦合组蛋白和DNA甲基化。
Nat Struct Mol Biol. 2009 Mar;16(3):304-311. doi: 10.1038/nsmb.1568. Epub 2009 Feb 22.
5
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.BIX-01294抑制G9a样蛋白赖氨酸甲基转移酶的结构基础。
Nat Struct Mol Biol. 2009 Mar;16(3):312-7. doi: 10.1038/nsmb.1560. Epub 2009 Feb 15.
6
Epigenetic control of T-helper-cell differentiation.T辅助细胞分化的表观遗传调控。
Nat Rev Immunol. 2009 Feb;9(2):91-105. doi: 10.1038/nri2487.
7
N-Benzyl-1-heteroaryl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamides as inhibitors of co-activator associated arginine methyltransferase 1 (CARM1).N-苄基-1-杂芳基-3-(三氟甲基)-1H-吡唑-5-甲酰胺作为共激活因子相关精氨酸甲基转移酶1(CARM1)的抑制剂
Bioorg Med Chem Lett. 2009 Feb 15;19(4):1218-23. doi: 10.1016/j.bmcl.2008.12.075. Epub 2008 Dec 24.
8
Arginine methylation regulates the p53 response.精氨酸甲基化调节p53反应。
Nat Cell Biol. 2008 Dec;10(12):1431-9. doi: 10.1038/ncb1802. Epub 2008 Nov 16.
9
Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells.组蛋白赖氨酸甲基转移酶的失调促成了人支气管上皮细胞的致癌转化。
Cancer Cell Int. 2008 Nov 3;8:15. doi: 10.1186/1475-2867-8-15.
10
H3K79 methylation profiles define murine and human MLL-AF4 leukemias.H3K79甲基化谱定义了小鼠和人类MLL-AF4白血病。
Cancer Cell. 2008 Nov 4;14(5):355-68. doi: 10.1016/j.ccr.2008.10.001.